Molecular pharmacokinetic mechanism of the drug-drug interaction between genistein and repaglinide mediated by P-gp
Open Access
- 1 May 2020
- journal article
- research article
- Published by Elsevier BV in Biomedicine & Pharmacotherapy
- Vol. 125, 110032
- https://doi.org/10.1016/j.biopha.2020.110032
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81874324, 81903706, U1608283)
- Natural Science Foundation of Liaoning Provincial (20170540293)
- Dalian Science and Technology Innovation Fund (2018J12SN065)
This publication has 48 references indexed in Scilit:
- Genistein, a Soy Phytoestrogen, Reverses Severe Pulmonary Hypertension and Prevents Right Heart Failure in RatsHypertension, 2012
- The Influence of MDR1 G2677T/A Genetic Polymorphisms on the Pharmacokinetics of Repaglinide in Healthy Chinese VolunteersPharmacology, 2012
- RepaglinideDrugs, 2012
- The Utility of In Vitro Data in Making Accurate Predictions of Human P-Glycoprotein-Mediated Drug-Drug Interactions: A Case Study for AZD5672Drug Metabolism and Disposition, 2010
- Effects of dietary flavonoids on the transport of cimetidine via P-glycoprotein and cationic transporters in Caco-2 and LLC-PK1 cell modelsXenobiotica, 2008
- Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetesDiabetes, Obesity and Metabolism, 2008
- A primer on the mechanics of P-glycoprotein the multidrug transporterPharmacological Research, 2007
- Rapid Identification of P-glycoprotein Substrates and InhibitorsDrug Metabolism and Disposition, 2006
- Synthesis and structure–activity relationships of novel pyrrolocarbazole lactam analogs as potent and cell-permeable inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)Bioorganic & Medicinal Chemistry Letters, 2006
- Risk-adjusted capitation funding models for chronic disease in Australia: alternatives to casemix fundingThe European Journal of Health Economics, 2002